A Good Consideration To Have

While the breast cancer battle rages on it’s vital that women at risk know some of the factors that may play a part in breast cancer risk. Breast density is actually one of many cancer risk factors.


Dr. Deborah Rhodes from the Mayo Clinic recently stated “There's this incredible national push toward educating women about breast density," Not a lot of women are aware that breast density is one of the single biggest inhibitors for mammography’s failure to spot breast cancer.


If you have any questions about breast cancer, breast density or any other issues please feel free to give us a call. Our talented staff here at Clermont radiology looks forward to answering any and all questions you may have.

ClermontRadiology.com

The Push For Low Dose

On the coverage front it has been proposed by CMS that low dose CT screening be covered, which represents a huge victory for diagnostic imaging as a whole. According to an article published by dotmed.com : “It completes the reimbursement picture for lung cancer screening,"

These news essentially mean that care and monitoring for lung cancer are making greater strides. The end result is yet to be seen but these pushes will also mean greater push for more CT innovations down the line, which means more effective treatment as well.

If you have any questions about diagnostic imaging procedures please feel free to give us a call. We at Clermont Radiology look forward to aiding you in your diagnostic imaging needs. 

ClermontRadiology.com

Ultrasound you say? I have an App for that

With most everything in the world today, there is always an app for something. Ultrasounds are apparently not the exception to the rule. The usage of tablets for ultrasounds is something that’s being touted as the next big thing, especially if ultrasound is vital and needed prior to arrival at a hospital.

The whole purpose behind the app is ensuring that care, especially in an emergency situation is faster and far more accurate. It may sound incredible but the fact is that this is the kind of thing that can make care more efficient.


If you have any questions with regards to diagnostic imaging procedures please feel free to give us a call. We here at Clermont Radiology look forward to answering any and all questions that you may have.


ClermontRadiology.com

Imaging for the Bladder

Narrow Band Imaging (NBI) technology has gotten FDA clearance. According to dotmed.com “NBI will allow physicians to remove small tumors in their offices, which will prevent costly operating room procedures if the tumor is spotted early enough.” 

This is a great because it cuts down on having to coordinate hospital visits for relatively simple procedures that shouldn't take quite as long as they normally do. According to the dotmed.com article “Blood absorbs NBI's blue and green light more so it makes the tissue appear darker and allows the surgeon to see vascular structures on the mucosal surface more clearly. 

The blue light is used to highlight the shallow capillaries and the green light highlights deeper veins.” This kind of advance may mean a new overall solution to an old problem, aiding in cutting down patient inconvenience, not to mention bladder tumors. 

If you have any questions about diagnostic imaging procedures please feel free to give us a call. Our team of dedicated professionals here at Clermont Radiology looks forward to answering all your questions and addressing all your concerns. 

ClermontRadiology.com

The Mammography Future

Mammography is great at detecting tumors and it’s also known as a source of discomfort that employs the use of radiation. There is something new on the horizon that may become the replacement for mammography. The new modality on the block is known as microwave tomography. 

According to dotmed.com “During a microwave tomography exam, the breast is suspended in a liquid bath that is surrounded by 16 antennae. One at a time, each antenna illuminates the breast with a low powered microwave signal while the other antennae receive the signals that are transmitted through the breast.” 

This new modality sounds like it may well be revolutionary in the fight against breast cancer. While it’s still early, it would be interesting to see how this will be playing out over the next ten years. 

If you have any questions about breast cancer screening please feel free to give us a call. Our team of dedicated professionals here at Clermont Radiology looks forward to answering any and all questions that you may have.  

ClermontRadiology.com

The Newest FDA Approval in the Alzheimer’s Fight

Alzheimer’s disease as well as dementia are two terrible diseases that not only hurt a patient, they hurt families. Dealing with either one of these very difficult diseases can take a major toll on everyone involved. The sad thing is that no amount of diagnostic imaging can really avoid either and help provide a good strong treatment program that will deal with either condition.

A CT scan, MRI scan, and any other test will reveal that it’s there and what the level it’s in. Now the FDA has made a move forward in order to work on the monitoring end of things. Vizamyl has been approved for the purpose of monitoring Alzheimer’s and dementia. The drug is basically a PET scan tracer that’s used to create color images for images normally seen in black and white.

The diagnosticimaging.com article stated that “Many Americans are evaluated every year to determine the cause of diminishing neurological functions, such as memory and judgment that raise the possibility of Alzheimer’s disease.” This kind of improvement helps because although it’s not a cure or a manner of prevention, it definitely aides in the battle for discovery.

Vizamyl will not tell you what stage Alzheimer’s is in, nor will it be used to predict whether or not it’s coming. The drug itself is for scanning purposes, but on the plus side a clear and more accurate scan is likely to help the patient in a greater way. The battle against Alzheimer’s and dementia is not likely to change for a long time. It will take much more research and far greater work to actually make progress.

To be able to see a colorful image and better interpret it is a step in the proper direction and hopefully it will mean that in the end better things will lie ahead. If you have any questions about diagnostic imaging procedures please feel free to give us a call. Our team of dedicated imaging professionals here at Clermont Radiology looks forward to answering all your questions and aiding you in your imaging needs. 

ClermontRadiology.com

What’s Good for the Liver

A lesion on the liver can mean any number of things. A complex condition in the liver can be a major problem. Treatment for any condition of the liver will succeed if the detection of the condition is early. Diagnostic imaging procedures such as the PET/CT scans are what are normally used in order to characterize lesions. It’s been recently speculated though that the PET/MRI might actually be better than the PET/CT. As stated in an article published by auntminnie.com “PET/MRI provided better diagnostic confidence due to soft-tissue contrast and complementary information from different MRI sequences.”

The study conducted in order to arrive at this conclusion is the first one conducted for this purpose. According to the study there is more accurate differentiation and the article explained that “MRI offers enhanced soft-tissue contrast and has proved particularly beneficial for patients with small liver lesions. The modality has shown superior results compared to CT and PET/CT for depicting and characterizing liver tumors.” While this is a first study it will be interesting to see if greater samples yield the same results.

All conditions affect people in different ways, when you think of how incredibly different people’s immune systems are. One patient can go through a liver lesion and issue easily while the other could succumb to greater effects almost immediately. The way the study was conducted there were 70 patients enrolled. Of the 70 patients 39 were men while 31 were women. The study was thorough and it employed experienced readers looking at the results of each sub modality and comparing findings.

There is still the fact that it was only 70 people with a median age of 56 with a plus/minus of 14 years. The problem with that is that the variance does not include or factor younger patients. There are too many factors that have yet to be considered to say that the results are a fact. It will be interesting to see if physicians start employing the PET/MRI more as a result of these findings or if more studies will be conducted in the future.

If you have any questions about diagnostic imaging procedures please feel free to give us a call. Our team of dedicated imaging experts here at Clermont Radiology looks forward to answering any questions you may have and helping you with all your imaging needs.